Literature DB >> 22139728

The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.

Takeshi Imamura1, Atsuhiko Hikita, Yasumichi Inoue.   

Abstract

Transforming growth factor-β (TGF-β) ligand is a multifunctional growth factor that regulates various cell behavior, such as cell proliferation, differentiation, migration, and apoptosis. Because TGF-β is a potent growth inhibitor, abnormalities in TGF-β signaling result in carcinogenesis. In addition to tumor suppressor function, TGF-β acts as an oncogenic factor. In particular, TGF-β signaling plays an important role during metastasis of breast cancer. Recently, epithelial-mesenchymal transition (EMT) has been shown to confer malignant properties such as cell motility and invasiveness to cancer cells and plays crucial roles during cancer metastasis. Moreover, breast stem-like cells exhibit EMT properties. Because TGF-β is a potent regulator of EMT as well as cell stemness, TGF-β signaling might play a crucial role in the regulation of breast cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139728     DOI: 10.1007/s12282-011-0321-2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  73 in total

1.  Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.

Authors:  Lara H El Touny; Anthony Vieira; Arnulfo Mendoza; Chand Khanna; Mark J Hoenerhoff; Jeffrey E Green
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

2.  TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.

Authors:  Dhiman Ghosh; Ilya V Ulasov; LiPing Chen; Lualhati E Harkins; Karolina Wallenborg; Parvinder Hothi; Steven Rostad; Leroy Hood; Charles S Cobbs
Journal:  Stem Cells       Date:  2016-07-04       Impact factor: 6.277

Review 3.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

4.  Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Authors:  Matthew D Dun; Robert J Chalkley; Sam Faulkner; Sheridan Keene; Kelly A Avery-Kiejda; Rodney J Scott; Lasse G Falkenby; Murray J Cairns; Martin R Larsen; Ralph A Bradshaw; Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

5.  Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient's survival?

Authors:  Eleftherios D Spartalis; Periklis Tomos; Petros Konofaos; Dimitrios Dimitroulis; Gregory Kouraklis
Journal:  Int J Clin Exp Med       Date:  2014-01-15

6.  Mutational landscape implicates epithelial-mesenchymal transition gene TGF-β2 mutations for uterine carcinosarcoma after adjuvant tamoxifen therapy for breast carcinoma.

Authors:  Ling Shen; Liangli Hong; Songxia Zhou; Guohong Zhang; Ruiqin Mai
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

7.  Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models.

Authors:  Chandraiah Godugu; Apurva R Patel; Ravi Doddapaneni; Srujan Marepally; Tanise Jackson; Mandip Singh
Journal:  J Control Release       Date:  2013-07-07       Impact factor: 9.776

Review 8.  Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.

Authors:  Maria V Bogachek; James P De Andrade; Ronald J Weigel
Journal:  Cancer Res       Date:  2014-12-18       Impact factor: 12.701

9.  Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells.

Authors:  Zhongguo Shan; Zhengxi Wei; Zahir A Shaikh
Journal:  Toxicol Appl Pharmacol       Date:  2018-07-17       Impact factor: 4.219

10.  Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.

Authors:  Tian-Yi Wang; Yin-Peng Huang; Ping Ma
Journal:  Tumour Biol       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.